Event Sponsors
Spotlight Speakers
Michael Kahn
Medical Affairs Operations Leader
Spark Therapeutics
Loreen Brown
Global Head, Patient Support Solutions
MEDOCITY
Featured Speakers
Amanda Bruno
VP & Head of RWE Oncology
BAYER
Ana Bozas
Associate Director, Global Medical Communications
Akcea Therapeutics
Andrew Rosen
Director of Global Data Generation
Ionis Pharmaceuticals
Anthony Page
SVP, Insights Analytics
WITHIN3
Barry Lubarsky
Executive Director, Medical Affairs Strategy
Alkermes
Caroline Schaffrath Demarco
Social Listening Lead
WITHIN3
Cathy Andorfer
US Field Medical, Dermatology Lead
Bristol Myers Squibb
Dave Thompson
Board of Directors
ISPOR
Edward Power
Vice President, North America Medical Affairs, Hospital Business
Pfizer
Eva Gallagher
Vice President, Head of Medical Affairs
Agios Pharmaceuticals
Eva Gonzalez
Field Medical Director, MSL Team Lead, Gastroenterology
SANOFI GENZYME
Fatima Ahmad
Head of Medical Communications
Spark Therapeutics
Florin Draica
US Senior Medical Director, Hospital Portfolio, Hospital Business Unit
Pfizer
Ivan Desviat
Director, Global Medical Education Excellence, Global Medical Affairs
ABBVIE
Jessica Wong
VP, Product Management & Strategy
ALUCIO
John Harris
Associate Director, Medical Training & Development
Deciphera Pharmaceuticals
John Young
Director, Commercial & Medical Affairs IT
Intercept Pharmaceuticals
Joni Fausett
VP, Field Medical Team
Genentech
Karen Rance
Director, Medical Affairs, NA
ALK Abello, Inc.
Kevin Anis Massoudi
Head of Government Affairs & Market Development, Middle East, India & Africa
Varian Medical Systems
Leann Pezdirtz
Head, Field Based Medicine
BOEHRINGER INGELHEIM
Loreen Brown
Global Head, Patient Support Solutions
MEDOCITY
Lori Lebson
Head, US Medical Affairs, Neurology & Immunology
EMD Serono, Inc.
Mansi Jamindar
Associate Global Medical Director, Type 2 Franchise, Immunology
Sanofi Genzyme
Mark Hanke
Sr. MSL
Alkermes
Mehul Desai
Associate Medical Director
Argenx
Melissa Maisenbacher
Certified Genetic Counselor, Associate Director, Clinical Projects
Natera
Michael Groaning
Global Medical Affairs Lead, Prostate Cancer
Amgen
Michael Kahn
Medical Affairs Operations Leader
SPARK THERAPEUTICS
Nami Pandit
Senior Director, Global Medical Affairs Immunology
SANOFI GANZYME
Paul O’Grady
Global Oncology Scientific Communications & Strategy Head
GlaxoSmithKline
Paul Rowe
VP, Head of Global Medical, Immunology
Sanofi Genzyme
Pranab Kalita
Global Category Medical Affairs,Respiratory & Skin Health Lead
GlaxoSmithKline
Rajesh Ghosh
Head, Digital Safety & Decision Support
Genentech
Roberto Orsenigo
Novartis
Medical Director
Samson Wu
VP, Global Medical Affairs Excellence
GlaxoSmithKline
Sandra Casiano
Senior Global Medical Director
Sanofi Genzyme
Scott McConnell
VP, Medical Affairs
Chiasma
Sherry Siegert
Senior Director, Medical Affairs
La Jolla Pharmaceutical Company
Stacey Gorski
Head, US Medical Excellence
ASTRAZENECA
Stacy Hurt
Patient Advocacy Consultant
Stan Tsvirko
Head, Medical Affairs Innovation Lab
Novartis
Tamara Donaldson
Director, Field Medical Affairs
Takeda
Todd Townsend
Regional Medical Scientific Director
Merck
Victoria I. Preys
Global Medical Affairs Oncology, Pipeline & Precision Medicine, Portfolio & Alliance Managem
Merck
Event Schedule
COVID-19 has accelerated digital transformation in the pharmaceutical industry. Companies were forced in short order to adopt multiple new digital techniques all at once in order to maintain continuity.
- Explore the impact, behavioral changes, and lessons learned as a result of COVID-19
- Share best practices on how to effectively navigate a digital world
AI has been the buzz of digital transformation in medical affairs. The incorporation of AI and digital tools into the life sciences industry has a range of tangible benefits. Understand how your company should position itself to meet the pace of innovation, patient and customer demands, and provider needs.
- Highlight how AI and digital technology is already advancing health care
- Consider the most likely changes brought by Ai in the short- and long-term
- Discuss how the advancement in AI and innovative tools will impact Medical Affairs
AI applications in healthcare and in medical affairs have been rapidly increasing over the past years and are expected to continue to do so, with a wide range of benefits, from automating medical operations routine tasks to informing clinical and therapeutic decisions. However, as with any new technologies, especially when deployed to complex and sensitive areas, there are many challenges and pitfalls.
- Explore privacy concerns and risks of perpetuating inequalities
- Discuss automation and AI challenges and how it changes companies' cultures and how people interact
“The greatest danger in times of turbulence is not the turbulence – it is to act with yesterday’s logic.” Peter Drucker
Participants will gain a deeper understanding of the value of social listening including:
- How to put the pieces together to paint a complete picture
- How social media and science intersect to influence opinions and behaviors
- How to demystify social listening to create value for Medical Affairs
- The role of technology and the human element in extracting insights and driving patient-centric strategy
The usefulness along with the quality and reliability of health information gathered via digital health (e.g. mobile apps) must be addressed before there is confidence in the reliability of digital health solutions and subsequent use by patients and researchers for assessing the value of healthcare interventions. This panel will discuss the current state of digital health technology and how it can appropriately be utilized to conduct HEOR and RWE studies.
- Dive into the pros and cons for using digital health technology in HEOR/RWE
- Discuss patient and stakeholders comfort level in participating in digital HEOR/RWE
- Offer insights on patient experiences, opportunities, and consequences
Understand how the medical affairs function is evolving to meet the needs of healthcare providers and their patients
- Review actionable, innovative, and data-driven tactics to enhance the value proposition of medical affairs
- Learn how to leverage AI to synthesize insights and measure the impact of engagement with providers
As one way of adapting to COVID conditions, an MSL team was able to recreate a showcase of investigator-initiated research in a virtual space. This allowed for rapid and convenient gathering of insights on external research, in a topic and format that turned out to be of high interest to KOLs and the broader community.
- Strategically align research to clarify critical data on topics of interest
- Explore virtual applications for sharing research across multiple KOLs and institutions
- Emphasize MSL flexibility in order to recreate the most successful interactions
Digital therapeutics have become an important component of the digital health ecosystem. They not only provide patients with next-level disease treatment, support, information, and management, but they also assist patients in becoming active participants in their own care. They are the pinnacle of personalized, technology-based health care and the next step in treatment.
- Target and treat specific disease conditions
- Explore mobile applications and devices
- Drive behavioral change
- Discuss how to enhance digital presence through Project ELEVATE (Enhance Leveraging our Expertise for Video/Audio Technological Experience)
- Lessons learned from concept creation to full scaling
- See the dramatic results
- Learn how you can build, foster collaboration, and implement a similar solution for your team
Medical education is rapidly shifting away from in-person classes to increase the accessibility of information digitally. New channels need to be optimized for medical education.
- Deliver information and education in the ideal format
- Focus on a tailored, agile approach aligned to the appropriate setting and audience
- Provide CME/MIME on the go for HCPs needing access
- Establish an agile and efficient content management and field distribution foundation
- Right size content modules by KOL preferences, engagement intent, and delivery channels
- Minimize errors and compliance risks through smart version control and associated document linkages
- Capture and analyze data to improve ongoing content development efforts
Digital Opinion Leaders (DOLs) hold a significant sway on online platforms and have mastered the art of scientific communication in a digital world. By involving DOLs, life science communicators can expand the authenticity and reach of their messages across social networks.
- Learn how to identify DOLs
- Map the online community of interest
- Develop a DOL engagement strategy
There is an increasing demand from HCPs to receive medical information anytime, anywhere in the right place at the right time. Omnichannel engagement offers the opportunity for Pharma to meet the increasingly complex demands of diverse customers while at the same time generating a large amount of data on how best to engage diverse HCPs.
- Outline what good omnichannel engagement should look like
- Utilize technology that integrates all data in one place
- Create personalized data
- Engage with stakeholders at all times on all available channels
With the large amount of players out there, selecting a vendor to partner with can seem like a daunting task. Bringing new systems onboard is a huge investment. Ensure you are selecting the correct vendors for your organization and the system delivers what you need.
- Illustrate the questions you should be asking
- Request a demo and ask other industry leaders who have already implemented these systems
- Focus on what you can get the system to do rather that what it can do
- Transition from a digital-first to a customer-first engagement model through a hybrid, tech-enabled approach
- Be thoughtful about targeting and segmentation
- Enhance your team’s ability to adapt to local challenges and opportunities
How can you play your part in changing company culture as a whole to embrace innovation?
- Adopt a digital mindset – maximize the value of digital technology for healthcare
- Address knowledge gaps
- Embrace the customer-centricity mindset
- Understand the innovation methodology
- Define the challenges
The expanding digital landscape creates broad opportunities for engagement leaving each country medical team to determine the best digital tools for HCP education. Learn how to differentiate your digital strategy to establish a scalable and aligned global to local medical education program.
- Develop patient centric content in partnership with global experts
- Integrate multichannel approach for digital medical education
- Dive into framework for unified global to local execution
- Discuss hybrid model to increase engagement in live and virtual environments
Many organizations struggle to identify, attract, and maintain the digital leadership they need. There are many moving parts to implementing a strong digital strategy, but at the heart of it is your team. Learn how to build an exceptional, data-driven team.
- Plan, execute, and hire the talent for your digital strategy
- Consider talent from outside of pharma
- Bring innovators in house to work with individual stakeholders to help ask good questions and design the technology to answer those questions
- Identify your business needs
- Consider the types of systems that already exist at your organization
-
Determine software development objective
The digital landscape of healthcare has accelerated due to COVID-19. Many organizations that were not up-to-date with the latest digital tools and strategies were left fumbling to find fast solutions to navigating healthcare in a digital environment. The pandemic will eventually come to an end but there are many digital tools that are here to stay.
- Continue providing care education for HCPs with the use of electronic communications and software without an in-person visit
- Empower virtual engagement and conferences among HCPs
- Support 3D virtual reality platforms that replicate live meetings
- Encourage collaboration tools that allow for big groups from different geographical
locations to work together
Event Partners
